Tackling the Antimicrobial Resistance “Pandemic” with Machine Learning Tools: A Summary of Available Evidence
Article in Microorganisms (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosis
Article in Drug Discovery Today (February 2024)
Gene expression analysis reveals GRIN1, SYT1, and SYN2 as significant therapeutic targets and drug repurposing reveals lorazepam and lorediplon as potent inhibitors to manage Alzheimer’s disease
Article in Journal of Biomolecular Structure and Dynamics (September 2023)